Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1976 2
1977 1
1978 3
1979 2
1980 5
1981 4
1982 2
1983 5
1984 5
1985 6
1986 5
1987 10
1988 13
1989 11
1990 12
1991 18
1992 19
1993 17
1994 18
1995 22
1996 23
1997 10
1998 17
1999 17
2000 14
2001 20
2002 24
2003 35
2004 31
2005 32
2006 37
2007 42
2008 41
2009 41
2010 43
2011 38
2012 32
2013 32
2014 43
2015 29
2016 25
2017 28
2018 37
2019 22
2020 29
2021 31
2022 21
2023 15
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

905 results

Results by year

Filters applied: . Clear all
Page 1
Interplay between platelets and coagulation.
Sang Y, Roest M, de Laat B, de Groot PG, Huskens D. Sang Y, et al. Among authors: de groot pg. Blood Rev. 2021 Mar;46:100733. doi: 10.1016/j.blre.2020.100733. Epub 2020 Jul 12. Blood Rev. 2021. PMID: 32682574 Free PMC article. Review.
Antiphospholipid syndrome.
Schreiber K, Sciascia S, de Groot PG, Devreese K, Jacobsen S, Ruiz-Irastorza G, Salmon JE, Shoenfeld Y, Shovman O, Hunt BJ. Schreiber K, et al. Among authors: de groot pg. Nat Rev Dis Primers. 2018 Jan 11;4:17103. doi: 10.1038/nrdp.2017.103. Nat Rev Dis Primers. 2018. PMID: 29321641 Review.
Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation.
Devreese KMJ, de Groot PG, de Laat B, Erkan D, Favaloro EJ, Mackie I, Martinuzzo M, Ortel TL, Pengo V, Rand JH, Tripodi A, Wahl D, Cohen H. Devreese KMJ, et al. Among authors: de groot pg. J Thromb Haemost. 2020 Nov;18(11):2828-2839. doi: 10.1111/jth.15047. J Thromb Haemost. 2020. PMID: 33462974 Free article.
European consensus conference on faecal microbiota transplantation in clinical practice.
Cammarota G, Ianiro G, Tilg H, Rajilić-Stojanović M, Kump P, Satokari R, Sokol H, Arkkila P, Pintus C, Hart A, Segal J, Aloi M, Masucci L, Molinaro A, Scaldaferri F, Gasbarrini G, Lopez-Sanroman A, Link A, de Groot P, de Vos WM, Högenauer C, Malfertheiner P, Mattila E, Milosavljević T, Nieuwdorp M, Sanguinetti M, Simren M, Gasbarrini A; European FMT Working Group. Cammarota G, et al. Among authors: de groot p. Gut. 2017 Apr;66(4):569-580. doi: 10.1136/gutjnl-2016-313017. Epub 2017 Jan 13. Gut. 2017. PMID: 28087657 Free PMC article.
Mother-to-infant microbiota transmission and infant microbiota development across multiple body sites.
Bogaert D, van Beveren GJ, de Koff EM, Lusarreta Parga P, Balcazar Lopez CE, Koppensteiner L, Clerc M, Hasrat R, Arp K, Chu MLJN, de Groot PCM, Sanders EAM, van Houten MA, de Steenhuijsen Piters WAA. Bogaert D, et al. Among authors: de groot pcm. Cell Host Microbe. 2023 Mar 8;31(3):447-460.e6. doi: 10.1016/j.chom.2023.01.018. Cell Host Microbe. 2023. PMID: 36893737 Free article.
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials.
Theelen WSME, Chen D, Verma V, Hobbs BP, Peulen HMU, Aerts JGJV, Bahce I, Niemeijer ALN, Chang JY, de Groot PM, Nguyen QN, Comeaux NI, Simon GR, Skoulidis F, Lin SH, He K, Patel R, Heymach J, Baas P, Welsh JW. Theelen WSME, et al. Among authors: de groot pm. Lancet Respir Med. 2021 May;9(5):467-475. doi: 10.1016/S2213-2600(20)30391-X. Epub 2020 Oct 20. Lancet Respir Med. 2021. PMID: 33096027 Clinical Trial.
Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.
Pietanza MC, Waqar SN, Krug LM, Dowlati A, Hann CL, Chiappori A, Owonikoko TK, Woo KM, Cardnell RJ, Fujimoto J, Long L, Diao L, Wang J, Bensman Y, Hurtado B, de Groot P, Sulman EP, Wistuba II, Chen A, Fleisher M, Heymach JV, Kris MG, Rudin CM, Byers LA. Pietanza MC, et al. Among authors: de groot p. J Clin Oncol. 2018 Aug 10;36(23):2386-2394. doi: 10.1200/JCO.2018.77.7672. Epub 2018 Jun 15. J Clin Oncol. 2018. PMID: 29906251 Free PMC article. Clinical Trial.
905 results